Results 51 to 60 of about 102,651 (313)

Venous thromboembolism (VTE) in post-prostatectomy patients [PDF]

open access: yes, 2023
Radical prostatectomy (RP) is one of the recommended treatments to achieve oncological outcomes in localized prostate cancer. However, a radical prostatectomy is a major abdominopelvic surgery.
Madaan, S.   +6 more
core  

Development of immunocompetent models for primary and metastatic ER+ breast cancer

open access: yesAnimal Models and Experimental Medicine, EarlyView.
This study explores syngeneic, immunocompetent models of ER+ breast cancer in 129S6/SvEv mice, using trackable tumor cells to model both primary tumors and metastasis. The models show promise, while also revealing limitations for studying advanced disease and immune interactions.
Devon M. Bull   +5 more
wiley   +1 more source

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

open access: yesThe Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi   +21 more
wiley   +1 more source

Reshaping medical education: Performance of ChatGPT on a PES medical examination

open access: yesCardiology Journal
BACKGROUND: We are currently experiencing a third digital revolution driven by artificial intelligence (AI), and the emergence of new chat generative pre-trained transformer (ChatGPT) represents a significant technological advancement with profound ...
Simona Wójcik   +5 more
doaj   +1 more source

Thromboembolic disease of the venous and the arterial system : two different entities or two different sides of the same coin? [PDF]

open access: yes, 2010
In this thesis, special attention was paid to renal disease as different components of the renal disease were previously linked to either VTE (venous thromboembolis) and arterial thromboembolis (ATE). Whereas the association between overt proteinuria and
Mahmoodi, Bakhtawar Khan,   +1 more
core  

Prophylactic Enoxaparin Reduces Symptomatic Venous Thromboembolism Compared With No Chemoprophylaxis Within 95 Days After Knee Arthroscopy

open access: yesArthroscopy, EarlyView.
Purpose To investigate whether prophylactic use of low‐molecular‐weight heparin (enoxaparin) after knee arthroscopy reduces the incidence of symptomatic venous thromboembolism (VTE) compared with no postoperative pharmacological prophylaxis. Methods We conducted a population‐based cohort study using linked national insurance and hospital data from ...
Aylin Albrecht   +5 more
wiley   +1 more source

The use of imaging in the diagnosis and treatment of thromboembolic pulmonary hypertension

open access: yesCardiology Journal
Chronic thromboembolic pulmonary hypertension (CTEPH) is a potentially life-threatening condition, classified as group 4 pulmonary hypertension (PH), caused by stenosis or occlusion of the pulmonary arteries due to unresolved thromboembolic material. The
Konstantin Szewczuk   +2 more
doaj   +1 more source

Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism

open access: yesHaematologica, 2016
Venous thromboembolism occurs frequently in cancer patients. Two variants in the factor 5 gene (F5), rs6025 encoding for the factor V Leiden mutation R506Q, and rs4524 encoding K858R, have been found to be associated with venous thromboembolism.
Olga V. Gran   +9 more
doaj   +1 more source

Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study. [PDF]

open access: yesPLoS ONE, 2014
BACKGROUND: Elevated platelet count is associated with risk of venous thromboembolism in cancer patients initiating chemotherapy. It is not known whether this risk by platelet count is causal or merely reflects the malignant disease.
Hilde Jensvoll   +3 more
doaj   +1 more source

A Metabolomic Signature Predicts Gout Flare Clinical Outcome Associated With Colchicine Prophylaxis

open access: yesArthritis &Rheumatology, EarlyView.
Objective This study investigated that serum metabolomics, before urate‐lowering therapy (ULT) initiation, could serve as a biomarker for responsiveness to colchicine prophylaxis in patients with gout commencing treat‐to‐target ULT. Methods We studied a multicenter prospective cohort (n = 409) initiating treat‐to‐target ULT plus colchicine prophylaxis.
Wenyan Sun   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy